We welcome strategic partnerships across the healthcare ecosystem — from suppliers and providers to investors, governments, and development finance institutions.
AfriPharma is building an integrated healthcare platform — and each of these partner categories plays a critical role in that ecosystem.
Hospitals, clinics, and healthcare systems across Zimbabwe and the SADC region — seeking a reliable, compliant pharmaceutical distribution partner.
Retail and institutional pharmacies looking to source quality-assured medicines from a MCAZ-compliant wholesale distributor across Zimbabwe and Botswana.
Manufacturers and supply-chain partners seeking market access and distribution coverage across Southern Africa — including Zimbabwe, Botswana, South Africa, and Zambia.
Ministries of health, regulatory authorities, and development agencies across the SADC region — supporting medicine access, supply security, and local manufacturing capacity.
Impact investors, venture capital, and development finance institutions — seeking exposure to Africa's healthcare infrastructure growth, with a clear pathway to manufacturing scale.
A platform built on commercial fundamentals, regulatory credibility, and a long-term manufacturing vision — designed for DFI alignment from inception.
A deliberately sequenced strategy: distribution cash flows fund manufacturing. Lower early-stage risk, faster path to revenue, and a built-in market for future manufactured products.
MCAZ WDP application in progress from day one. GDP-aligned QMS operational. Compliance posture designed to meet DFI due diligence requirements across IFC, AfDB, and DFC.
Founded by a PharmD with 12+ years in sterile injectables manufacturing and regulatory audit experience across FDA, EMA, PMDA, ANVISA, Health Canada, and Israel MoH.
Two entities incorporated in 2026 (Zimbabwe, Botswana). South Africa, Zambia, and Mozambique in the pipeline. A SADC-wide footprint built for regional scale.
ParaFlow™ paracetamol IV designed from inception for WHO Prequalification — enabling institutional procurement access through UNICEF, UNFPA, and national tender programs.
Corporate structure — Holdings LLC → Mauritius GBC → OpCos — designed for OECD-compliant transfer pricing, DFI co-investment readiness, and multi-generational governance.
AfriPharma is actively engaging with government agencies, regulatory authorities, and development organizations across the SADC region — including the Zambia Development Agency (ZDA), ZAMRA, ZAMSA, and the Zimbabwe Ministry of Health.
Our platform is designed to support public health objectives: improving medicine availability, strengthening supply chains, creating pharmaceutical sector employment, and building the foundation for domestic manufacturing capacity.
